Clinical Trial Update: Switching From Efavirenz to Atazanavir/ Ritonavir in HIV-infected Subjects With Good Virologic Suppression [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating switching virologically suppressed HIV patients from efavirenz to ritonavir-boosted atazanavir; the study was terminated and results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Mitochondrial Dysfunction

Drugs mentioned

• Norvir (ritonavir)
• REYATAZ (atazanavir)
• Sustiva (efavirenz)

Snippet

Sponsor: The Cleveland Clinic | Conditions: HIV Infection, Mitochondrial Dysfunction | Phase 4 | Status: TERMINATED | Results posted: 2017-08-11